Salk polio vaccine field-trial results announced in 1955
On 12 April 1955, Thomas Francis Jr. announced the results of the large trial of Jonas Salk’s inactivated polio vaccine. Evidence that vaccination could prevent paralytic disease transformed public expectations, while leaving the work of safe production and widespread delivery ahead.
The difference between prevention and treatment
Polio created widespread anxiety because infection could cause paralysis, including damage affecting breathing. A vaccine offered a way to reduce the risk before illness occurred; it was not a treatment that reversed existing paralysis. Jonas Salk’s approach used inactivated poliovirus. The virus was rendered unable to reproduce while retaining features capable of stimulating an immune response. This made the project an important demonstration of protection through a non-replicating preparation rather than through deliberately producing a mild live infection.
The announcement in Ann Arbor
On 12 April 1955, Thomas Francis Jr. presented the field-trial findings at the University of Michigan. The trial had involved more than 1.8 million children, with a design large enough to compare outcomes in different groups. The university preserves its original press release, which reported strong protection against paralytic polio. The percentages concerned effectiveness measured in the trial, not a promise that every vaccinated child would be protected under every circumstance. Evidence replaced hope with a result that could be evaluated.
Why the trial mattered
Salk and his colleagues had developed the vaccine, but an independent evaluation was essential to assessing its usefulness on a large scale. Parents, children, health workers, donors and analysts all contributed to the effort. Its announcement made statistical evidence a major public event. The World Health Organization records that the vaccine was licensed the same day. Approval opened the way to wider vaccination, but producing reliable doses and reaching children remained separate tasks requiring organization, quality control and continued public cooperation.
A beginning for wider protection
Inactivated polio vaccine should be distinguished from the later oral vaccine associated with Albert Sabin, which used weakened live virus. Both contributed to subsequent control efforts in different ways. Nor did the 1955 announcement mean that the disease had already disappeared. Its significance was that a preventive tool had passed a major test. The laboratory illustration represents the collective scientific work in an imagined period setting; it is not a photograph of Francis’s announcement or a record of a particular experiment.
The Circle Game - Joni Mitchell (Titi Stier Cover)
Titi Stier
A later cover of a song by Joni Mitchell, who survived childhood polio before a vaccine was available. This personal link to the disease is thematic; the song and recording postdate the 1955 announcement.
Listen on SoundCloud ↗Follow the evidence.
- University of Michigan: Original vaccine trial announcement ↗
- Salk Institute: Jonas Salk and the inactivated vaccine ↗
- World Health Organization: History of polio vaccination ↗
- Joni Mitchell: Childhood experience of polio ↗
- Titi Stier: The Circle Game cover ↗
AI-assisted writing, with institutional and primary sources. Illustration is a reconstruction, not an archival photograph. Published October 31, 2026; updated October 31, 2026. Our approach
